ES8101035A1 - Un procedimiento de preparacion de nuevos derivados de 3-(a-minoetil)fenol - Google Patents

Un procedimiento de preparacion de nuevos derivados de 3-(a-minoetil)fenol

Info

Publication number
ES8101035A1
ES8101035A1 ES484343A ES484343A ES8101035A1 ES 8101035 A1 ES8101035 A1 ES 8101035A1 ES 484343 A ES484343 A ES 484343A ES 484343 A ES484343 A ES 484343A ES 8101035 A1 ES8101035 A1 ES 8101035A1
Authority
ES
Spain
Prior art keywords
aminoethyl
phenols
novel
carbon atoms
diarylmethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES484343A
Other languages
English (en)
Other versions
ES484343A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9212922&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES8101035(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of ES8101035A1 publication Critical patent/ES8101035A1/es
Publication of ES484343A0 publication Critical patent/ES484343A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16—Tryptamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Indole Compounds (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE DERIVADOS DE 3-(AMINOETIL)FENOL. CONSISTE EN HIDROLIZAR UN COMPUESTO DE FORMULA GENERAL (I), OBTENIENDOSE UN COMPUESTO DE FORMULA GENERAL (II). LA HIDROLISIS SE EFECTUA POR MEDIO DE *FORMULA* UNA DISOLUCION CONCENTRADA DE ACIDO BROMHIDRICO O POR MEDIO DE CLORHIDRATO DE PIRIDINA AL REFLUJO DE LA MEZCLA DE REACCION. TRATAMIENTO DE SINDROMES NEUROLOGICOS DE ORIGEN EXTRAPIRAMIDAL. U
ES484343A 1978-09-22 1979-09-21 Un procedimiento de preparacion de nuevos derivados de 3-(a-minoetil)fenol Granted ES484343A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7827190A FR2436773A1 (fr) 1978-09-22 1978-09-22 Nouveaux derives du 3-(aminoethyl) phenol et leurs sels, procede de preparation et application a titre de medicaments

Publications (2)

Publication Number Publication Date
ES8101035A1 true ES8101035A1 (es) 1980-12-01
ES484343A0 ES484343A0 (es) 1980-12-01

Family

ID=9212922

Family Applications (1)

Application Number Title Priority Date Filing Date
ES484343A Granted ES484343A0 (es) 1978-09-22 1979-09-21 Un procedimiento de preparacion de nuevos derivados de 3-(a-minoetil)fenol

Country Status (15)

Country Link
US (1) US4242355A (es)
JP (1) JPS5545684A (es)
AT (1) AT367734B (es)
AU (1) AU526895B2 (es)
BE (1) BE878916A (es)
CA (1) CA1132543A (es)
CH (1) CH641438A5 (es)
DE (1) DE2938302A1 (es)
ES (1) ES484343A0 (es)
FR (1) FR2436773A1 (es)
GB (1) GB2033381B (es)
IT (1) IT7950223A0 (es)
NL (1) NL7907040A (es)
SE (1) SE7906472L (es)
ZA (1) ZA794267B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678375A (en) * 1984-03-05 1987-07-07 Gagle Company, Inc. Covering or liner system and method for constructing the same
US4788010A (en) * 1985-04-24 1988-11-29 E. R. Squibb & Sons, Inc. Amino substituted benzenepropanols
US4896993A (en) * 1987-10-20 1990-01-30 Bohnhoff William W Mat for providing a stabilized surface over sand or other loose soil and method of fabricating the same
FR2646347B1 (fr) * 1989-04-28 1991-08-23 Roussel Uclaf Nouveau derive d'hydroxyphenethylamine et ses sels, procede de preparation, application a titre de medicaments et utilisation comme outil pharmacologique specifique
GB9017390D0 (en) * 1990-08-08 1990-09-19 Norgine Ltd Improvements in or relating to propylamine derivatives
US5102048A (en) * 1990-08-31 1992-04-07 Bohnhoff William W Irrigation head support
US5250340A (en) * 1990-08-31 1993-10-05 Bohnhoff William W Mat for stabilizing particulate materials
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5428037A (en) * 1993-04-09 1995-06-27 Syntex Pharmaceuticals, Ltd. Heterocyclic derivatives in the treatment of Ischaemia and related diseases
US5993860A (en) * 1993-06-17 1999-11-30 Venture Lending NSADI delivery employing a powdered hydrocolloid gum obtainable from higher plants
WO1995004723A1 (fr) * 1993-08-04 1995-02-16 Yamanouchi Pharmaceutical Co., Ltd. Derive d'imidazolylalkylamine et composition pharmaceutique contenant ledit derive
CZ290670B6 (cs) 1994-10-21 2002-09-11 Nps Pharmaceuticals, Inc. Sloučeniny modulující receptory anorganických iontů a farmaceutický prostředek, který je obsahuje
PT907631E (pt) * 1996-05-01 2003-10-31 Nps Pharma Inc Compostos inorganicos activos como receptores de ioes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2525674A (en) * 1949-01-21 1950-10-10 Upjohn Co Beta-(ortho-methoxy) phenyl-isopropyl 2-thenyl alkyl amines and salts thereof
FR2356417A1 (fr) * 1976-07-01 1978-01-27 Roussel Uclaf Nouveaux derives de monohydroxyphenethylamines et leurs sels, procede de preparation et application a titre de medicaments de ces nouveaux produits

Also Published As

Publication number Publication date
AU526895B2 (en) 1983-02-03
US4242355A (en) 1980-12-30
GB2033381A (en) 1980-05-21
CA1132543A (fr) 1982-09-28
FR2436773B1 (es) 1981-04-10
BE878916A (fr) 1980-03-21
CH641438A5 (fr) 1984-02-29
ES484343A0 (es) 1980-12-01
ATA610479A (de) 1981-12-15
DE2938302A1 (de) 1980-04-03
GB2033381B (en) 1982-09-15
FR2436773A1 (fr) 1980-04-18
ZA794267B (en) 1980-08-27
NL7907040A (nl) 1980-03-25
AT367734B (de) 1982-07-26
JPS5545684A (en) 1980-03-31
IT7950223A0 (it) 1979-09-10
AU5108779A (en) 1980-03-27
SE7906472L (sv) 1980-03-23

Similar Documents

Publication Publication Date Title
ES8101035A1 (es) Un procedimiento de preparacion de nuevos derivados de 3-(a-minoetil)fenol
ES480542A1 (es) Metodo para producir derivados de imidazol.
IE42216L (en) Benzomorphane derivatives
IE40570L (en) Benzylamine derivatives
IE820401L (en) N-£4-(indolyl)-piperidino-alkyl|-benzimidazolines
ES8404356A1 (es) Procedimiento de preparacion de nuevas pirimido-quinoxalinas.
ES8504738A1 (es) Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol
IE41440L (en) Thiatetracyclines
AU541413B2 (en) 2-(1,4-benzodioxan-2-ylalicyl)imidazoles
ES477785A1 (es) Procedimiento para la preparacion de nuevas 2-fenilimino- imidazolidinas sustituidas.
ES483039A1 (es) Procedimiento de preparacion de nuevas imidazoquinoxalinas
ES478643A1 (es) Procedimiento de preparacion de nuevos derivados de la n-fe-nilalanina.
GB1409648A (en) Substituted pyrrolidinemethanol compounds and pharmaceutical compositions thereof
ES461785A1 (es) Un metodo para la preparacion de un ester de acido behenico.
ES8305758A1 (es) "un procedimiento para la preparacion de 2-(1,4-benzodioxan-2-il-metil)-imidazolina".
ES8104247A1 (es) Procedimiento para la preparacion de 3-alcoxi-6-alquiliden- hidracionopiridacina
ES2003549A6 (es) Un procedimiento para la preparacion de derivados de cefalosporina.
SE7412163L (es)
EP0103357A3 (en) Substituted phenylpiperazine compounds suitable as antihypertensive agents, and processes for their production
ES473038A1 (es) Procedimiento para la obtencion de 2-guanidinometil-indoli- nas
ES468133A1 (es) Procedimiento para preparar derivados del cornezuelo del centeno
IE40561B1 (en) Alkylmercaptomethylquinoxaline 1,4-dioxides and derivatives thereof
IE790924L (en) 1,3-benzodioxin derivatives
IE41906L (en) But-2-enoanilides
ES445343A1 (es) Procedimiento para la preparacion de derivados cuaternarios de xantinil-alcohil-nortropina.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19841024